Saltar al contenido
Merck

Fusidic acid in other infections.

International journal of antimicrobial agents (1999-10-21)
C Golledge
RESUMEN

Fusidic acid, both systemic and topical, has been used for a wide variety of less common infections. Efficacy for oral fusidic acid has been demonstrated in the treatment of Clostridium difficile colitis and in staphylococcal infections in patients with cystic fibrosis. Topical fusidic acid gel is also effective in bacterial conjunctivitis and other minor external eye infections, and may be effective in reducing bacterial flora in the conjunctival sac prior to eye surgery. Studies suggest a potential role for fusidic acid in neurosurgical prophylaxis, as adjunctive therapy in bacterial endophthalmitis and Legionella pneumonia, and in leprosy. Topical fusidic acid has no effect in the treatment of chlamydial conjunctivitis or the prevention of staphylococcal infections in patients on continuous ambulatory peritoneal dialysis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Fusidic acid
Fusidic acid, European Pharmacopoeia (EP) Reference Standard
Fusidic acid for peak identification, European Pharmacopoeia (EP) Reference Standard